However, BoNE prioritized other models over DSS, many of which accurately recapitulate the PPARα and Pparγ-downregulation that is observed in the barrier-defect transcript signature in human IBD (Fig. 2e). This evidence concerns the gene PPARA and inflammatory bowel disease.